Register Now
Course Information
alert
MyCME will be down for routine maintenance starting at 5:00 am Sunday, November 18, 2018 and ending at 8:00 am Sunday, November 18, 2018. You will not be able to claim CME credit at that time. We are sorry for the inconvenience.

Mastering the Mitral Valve



The History of the Mitral Valve
A luncheon discussion with Lars Svensson, MD, PhD and David H. Adams, MD


With greater than 2.5 million people affected in the US alone, mitral valve disease is one of the most common valve diseases with considerable prevalence, particularly in the growing elderly population. There is also a shift in etiologies from predominantly rheumatic to predominantly degenerative.

This program is designed to bring together cardiologists, surgeons, and other healthcare providers to address the contemporary and future management of mitral valve disease and define the complementary role of medical, transcatheter and surgical therapies. The course will emphasize case-based learning designed to engage learners in discussions, debates, and critical decision-making for this condition.

Target audience:

This course is intended for cardiothoracic surgeons, cardiologists, interventional cardiologists, internists, nurses, physician assistants and all health care professionals involved in the evaluation, diagnosis and/or management of patients with mitral valve disease.

Learning Objectives:

After participating in this educational activity, practitioners will be able to do the following:

  • Assess the role of advanced echo techniques, stress imaging, CT and CMR in characterizing mitral valve disease and guiding management.
  • Incorporate the evidence on contemporary surgical, percutaneous, and device-based treatment options into clinical decision-making for patients with mitral disease.
  • Present the pros and cons of mitral valve repair vs replacement, repair techniques, and minimally invasive approaches.
  • Analyze the cost effectiveness of new technologies in light of changes in the health care environment.
  • Describe strategies for treating challenging developments associated with degenerative mitral valves including tricuspid repair, atrial fibrillation ablation, and Barlow’s valve repair.
  • Describe the recent technologies and techniques for transcatheter repair and replacement and the clinical evidence available through current trials.